1. Home
  2. CSTM vs TARS Comparison

CSTM vs TARS Comparison

Compare CSTM & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Constellium SE (France)

CSTM

Constellium SE (France)

HOLD

Current Price

$34.55

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$65.11

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTM
TARS
Founded
2010
2016
Country
France
United States
Employees
11500
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
2.7B
IPO Year
2012
2020

Fundamental Metrics

Financial Performance
Metric
CSTM
TARS
Price
$34.55
$65.11
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$30.75
$89.00
AVG Volume (30 Days)
2.1M
595.9K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
405.26
48.21
EPS
1.42
N/A
Revenue
$8,449,000,000.00
$451,360,000.00
Revenue This Year
$21.46
$56.43
Revenue Next Year
$0.50
$30.19
P/E Ratio
$23.51
N/A
Revenue Growth
15.19
146.71
52 Week Low
$11.60
$38.51
52 Week High
$34.35
$85.25

Technical Indicators

Market Signals
Indicator
CSTM
TARS
Relative Strength Index (RSI) 66.42 51.22
Support Level $14.04 $61.24
Resistance Level N/A $67.24
Average True Range (ATR) 1.33 3.59
MACD 0.08 0.09
Stochastic Oscillator 98.71 81.30

Price Performance

Historical Comparison
CSTM
TARS

About CSTM Constellium SE (France)

Constellium SE is engaged in the development, manufacture and sale of a broad range of high value-added specialty rolled and extruded aluminum products to the aerospace, space, defense, packaging, automotive, commercial transportation and general industrial end-markets. Its business model is to add value by converting aluminum into semi-fabricated and, in some instances, fully-fabricated alloyed aluminum products that meet stringent and performance-critical requirements from customers. It operates through three segments: Aerospace & Transportation Operating Segment, Packaging & Automotive Rolled Products Operating Segment, and Automotive Structures & Industry Operating Segment. It serves Aerospace, Packaging and Automotive and operates in the United States, France, Germany and others.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: